Maze Therapeutics, Inc. ($MAZE)
Filing Information
| Accession Number | 0002050172-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 9, 2026 |
| Document Date | Jan 7, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
75,468
Total Value
$1,273,424.39
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D & CMO | Common Stock | โ | Jan 7, 2026 | Exercise/Conversion | 25,156 | $10.42 | $262,125.52 | 25,156 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Jan 7, 2026 | Sale | 25,156 | $40.20 | $1,011,298.87 | 0 | Direct | โ | View Details | |
President, R&D & CMO | Stock Option (Right to Buy) | Derivative | Jan 7, 2026 | Exercise/Conversion | 25,156 | $0.00 | $0.00 | 312,407 | Direct | โ | View Details |